Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-005414-40-IT (EUCTR)	21/12/2007	28/11/2007	Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - ND	Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - ND	Patients with an established and stable Multiple Sclerosis (according to Poser criteria). MedDRA version: 9.1;Level: LLT;Classification code 10028245;Term: Multiple sclerosis	Trade Name: KEPPRA INN or Proposed INN: Levetiracetam	AZIENDA SANITARIA N. 3 GENOVESE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy
2	NCT00423527 (ClinicalTrials.gov)	January 2007	16/1/2007	Levetiracetam in Central Pain in Multiple Sclerosis(MS)	Double-blind, Randomised,Placebo-controlled Trial of Levetiracetam in Central Pain in Multiple Sclerosis	Multiple Sclerosis	Drug: levetiracetam	Odense University Hospital	NULL	Completed	18 Years	N/A	Both	30	Phase 4	Denmark
3	EUCTR2006-000397-71-DK (EUCTR)	16/05/2006	02/05/2006	Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosis	Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosis		Trade Name: Keppra Product Name: Levetiracetam Product Code: ucb L059	Søren H. Sindrup, Department of Neurology, Odense University Hospital	NULL	Not Recruiting			Female: yes Male: yes	30		Denmark
4	EUCTR2005-003903-35-GB (EUCTR)	19/01/2006	19/12/2005	: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis	: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis	Multiple Sclerosis	Trade Name: Keppra 250mg INN or Proposed INN: Levetiracetam Trade Name: Keppra 500mg Product Name: Keppra ®	Newcastle-upon-Tyne Hospitals NHS Trust	NULL	Not Recruiting			Female: yes Male: yes	20	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes	United Kingdom
5	EUCTR2005-001776-13-DE (EUCTR)	05/08/2005	26/09/2006	Efficacy of Levetiracetam in the treatment of spasticity in MS: a ranomized double blind cross over study	Efficacy of Levetiracetam in the treatment of spasticity in MS: a ranomized double blind cross over study	Multiple Sclerosis	Product Name: Levetiracetam	Organisation name was not entered	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24		Germany